The Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) is an immunochromatographic test system intended for the qualitative detection of KPC-type carbapenemase in bacterial colonies. The assay is a prescription-use laboratory assay which can aid in the diagnosis of KPC-type carbapenem resistant strains.
Name |
Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) |
Method |
Lateral Flow Assay |
Sample type |
Bacterial colonies |
Specification |
25 tests/kit |
Detection time |
10-15 min |
Detection objects |
Carbapenem-resistant Enterobacteriaceae (CRE) |
Detection type |
KPC |
Stability |
The K-Set is stable for 2 years at 2°C-30°C |
Carbapenem antibiotics are one of the most effective drugs for the clinical control of pathogenic infections. Carbapenemase-producing organisms (CPO) and carbapenem-resistant Enterobacter (CRE) have become a global public health issue due to their broad-spectrum drug resistance, and treatment options for patients are very limited. People worldwide should pay great attention on preventing the spread of CRE, which, if not limited, will seriously affect the clinical treatment of many diseases, making it increasingly difficult to cure and control diseases.
Usually, healthcare providers can help prevent the spread of CRE by
……
All these indicate the importance of early detection of CRE. To develop rapid diagnostic products is of great significance for the early typing of drug-resistant strains, the guidance of medication, and the improvement of human’s medical and health standards.
Carbapenemase refers to a type of β-lactamase that can at least significantly hydrolyze imipenem or meropenem, including A, B, D three types of enzymes classified by Ambler molecular structure. Class A, such as KPC-type carbapenemase, have been detected primarily in Enterobacteriaceae bacteria. Klebsiella pneumoniae carbapenemase, briefed as KPC, has become one of the most important contemporary pathogens, while the optimal treatment remains undefined. Infections due to KPCs are associated with high therapeutic failure and mortality rates of at least 50%.
Model |
Description |
Product code |
CPK-01 |
25 tests/kit |
CPK-01 |